Rigel Pharmaceuticals reported $120.52M in Current Assets for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Agenus AGEN:US $ 290.48M 41.49M
Amgen AMGN:US $ 19322M 802M
Anika Therapeutics ANIK:US $ 167.86M 2.53M
Applied Genetic Technologies AGTC:US $ 70.53M 4.84M
Arrowhead Research ARWR:US $ 432.39M 14.76M
AstraZeneca AZN:LN 20.92B 1.73B
Astrazeneca AZN:US 20.92B 1.73B
Biomarin Pharmaceutical BMRN:US $ 2517.6M 123.57M
Bristol Myers Squibb BMY:US $ 30186M 65M
Celldex Therapeutics CLDX:US $ 390.7M 20.14M
Chemocentryx CCXI:US $ 351.63M 82.46M
Daiichi Sankyo 4568:JP Y 1367130M 21859M
Eli Lilly And LLY:US $ 17115.2M 150.5M
Halozyme Therapeutics HALO:US $ 988.69M 62.4M
Heron Therapeutics HRTX:US $ 222.59M 31.83M
Immunogen IMGN:US $ 373.87M 82.84M
Intrexon XON:US $ 154.94M 1.69M
IONIS PHARMACEUT IONS:US $ 2253.12M 91.92M
Karyopharm Therapeutics KPTI:US $ 242.45M 34.09M
Ligand Pharmaceuticals LGND:US $ 276.07M 188.68M
Macrogenics MGNX:US $ 218.2M 61.36M
Neurocrine Biosciences NBIX:US $ 1019.3M 1.1M
Regeneron Pharmaceuticals REGN:US $ 15529.9M 1223.9M
Rigel Pharmaceuticals RIGL:US $ 120.52M 18.42M
Ultragenyx Pharmaceutical RARE:US $ 678.54M 28.98M
Veracyte VCYT:US $ 235.04M 3.44M